Mark Hopman, the Chief Commercial Officer of $BBNX, sold 16,158 shares of the company on 08-19-2025 for an estimated $268,376. We received data on the trade from a recent SEC filing. This was a sale of approximately 32.1% of their shares of this class of stock. Following this trade, they now own 34,132 shares of this class of $BBNX stock.
$BBNX Insider Trading Activity
$BBNX insiders have traded $BBNX stock on the open market 17 times in the past 6 months. Of those trades, 0 have been purchases and 17 have been sales.
Here’s a breakdown of recent trading of $BBNX stock by insiders over the last 6 months:
- MARK HOPMAN (Chief Commercial Officer) has made 0 purchases and 4 sales selling 17,026 shares for an estimated $283,905.
- STEPHEN FEIDER (Chief Financial Officer) has made 0 purchases and 4 sales selling 7,084 shares for an estimated $121,954.
- SEAN SAINT (President & CEO) has made 0 purchases and 3 sales selling 3,439 shares for an estimated $61,525.
- MIKE MENSINGER (Chief Product Officer) has made 0 purchases and 3 sales selling 1,115 shares for an estimated $19,947.
- STEVEN JON RUSSELL (Chief Medical Officer) has made 0 purchases and 3 sales selling 1,039 shares for an estimated $18,588.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BBNX Analyst Ratings
Wall Street analysts have issued reports on $BBNX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 07/30/2025
- Lake Street issued a "Buy" rating on 06/12/2025
- Wolfe Research issued a "Outperform" rating on 05/30/2025
- Stifel issued a "Buy" rating on 02/24/2025
- Piper Sandler issued a "Overweight" rating on 02/24/2025
- Leerink Partners issued a "Outperform" rating on 02/24/2025
To track analyst ratings and price targets for $BBNX, check out Quiver Quantitative's $BBNX forecast page.
$BBNX Price Targets
Multiple analysts have issued price targets for $BBNX recently. We have seen 9 analysts offer price targets for $BBNX in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- Jeff Johnson from Baird set a target price of $17.0 on 07/30/2025
- Richard Newitter from Truist Securities set a target price of $21.0 on 07/30/2025
- Frank Takkinen from Lake Street set a target price of $30.0 on 06/12/2025
- David Roman from Goldman Sachs set a target price of $16.0 on 05/30/2025
- Mike Polark from Wolfe Research set a target price of $20.0 on 05/30/2025
- Mathew Blackman from Stifel set a target price of $25.0 on 02/24/2025
- Matt O'Brien from Piper Sandler set a target price of $26.0 on 02/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
